US2022064629A1PendingUtilityA1

Cellular Libraries of Peptide Sequences (CLiPS) and Methods of Using the Same

Assignee: UNIV CALIFORNIAPriority: Aug 31, 2005Filed: Apr 12, 2021Published: Mar 3, 2022
Est. expiryAug 31, 2025(expired)· nominal 20-yr term from priority
C07K 2319/60C12N 15/1044C12N 15/1037G01N 21/6486C40B 30/04C07K 2319/03C12Q 1/37C07K 2319/22C40B 40/10C40B 40/02C07K 14/245
75
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides compositions including peptide display scaffolds that present at least one candidate peptide and at least one detectable moiety in at least one of the N-terminal and C-terminal candidate peptide presenting domains that when expressed in a cell are accessible at a surface of the cell outermembrane. In addition, the present invention also provides kits and methods for screening a library of cells presenting the candidate peptides in peptide display scaffolds to identify a ligand for an enzyme.

Claims

exact text as granted — not AI-modified
1 - 46 . (canceled) 
     
     
         47 . A method of identifying a substrate for a target protease, the method comprising:
 contacting a plurality of cells with a background mixture,   wherein the background mixture does not include the target protease and wherein each of the plurality of cells expresses a peptide display scaffold; and   enriching the plurality of cells for cells that are not cleaved by background mixture,   wherein the peptide display scaffold comprises a fusion protein having the structure [D 1 -C 1 ]-TM-[D 2 ],   wherein TM is a circularly permuted transmembrane protein, wherein C 1  comprises a candidate substrate of the target protease, wherein D 1  is a first detectable moiety and is a heterologous peptide or polypeptide, wherein D 2  is a second detectable moiety and is a heterologous peptide or polypeptide, wherein D 1  and D 2  are not the same; and wherein D 1 , D 2 , and C 1  are exposed at an extracellular surface of the cell outer membrane.   
     
     
         48 . The method of  claim 47 , wherein the step of enriching the plurality of cells comprises:
 depleting the plurality of cells that are cleaved by the background mixture.   
     
     
         49 . The method of  claim 47  comprising:
 contacting the enriched plurality of cells with the target protease. 
 
     
     
         50 . The method of  claim 49  comprising:
 enriching the enriched plurality of cells for cells that are cleaved by the target protease. 
 
     
     
         51 . The method of  claim 50 , wherein the step of enriching the enriched plurality of cells comprises:
 isolating the cells from the enriched plurality of cells that are cleaved by the target protease; and   amplifying the isolated cells.   
     
     
         52 . The method of  claim 47  comprising:
 detecting the presence or absence of a D 1  signal and a D2 signal for at least one cell, wherein said detecting indicates whether C 1  is cleaved by the background mixture. 
 
     
     
         53 . The method of  claim 49  comprising:
 detecting the presence or absence of a D 1  signal and a D2 signal for at least one cell, wherein said detecting indicates whether C 1  is cleaved by the target protease. 
 
     
     
         54 . The method of  claim 47 , wherein the background mixture comprises a cellular lysate or a tissue extract. 
     
     
         55 . The method of  claim 47 , wherein the fusion protein comprises at least one linker, wherein the linker is between C 1  and TM, or wherein the linker is between D 2  and TM. 
     
     
         56 . The method of  claim 47 , wherein at least one of detectable moieties D 1  and D 2  comprises an affinity tag. 
     
     
         57 . The method of  claim 47 , wherein at least one of detectable moieties D 1  and D 2  comprises a fluorescent protein. 
     
     
         58 . The method of  claim 52 , wherein the detecting step comprises detecting the presence of a detectable signal of D 1  and detecting the absence of a detectable signal of D 2  that is above a background level of a detectable D 2  signal. 
     
     
         59 . The method of  claim 53 , wherein the detecting step comprises detecting the presence of a detectable signal of D 1  and detecting the absence of a detectable signal of D 2  that is above a background level of a detectable D 2  signal. 
     
     
         60 . The method of  claim 47 , wherein the D 1  and C 1  are located at an N-terminal domain of the fusion protein and the D 2  is located at a C-terminal domain of the fusion protein. 
     
     
         61 . The method of  claim 47 , wherein the D 1  and C 1  are located at a C-terminal domain of the fusion protein and the D 2  is located at an N-terminal domain of the fusion protein. 
     
     
         62 . The method of  claim 47 , wherein the circularly permuted transmembrane protein is a circularly permuted bacterial outer membrane selected from the group consisting of: a circularly permuted OmpX, a circularly permuted OmpA, and a circularly permuted OmpT. 
     
     
         63 . A method of identifying a substrate for a target protease, the method comprising:
 contacting a plurality of cells with a background mixture, wherein the background mixture does not include the target protease and wherein each of the plurality of cells expresses a peptide display scaffold;   enriching the plurality of cells that are not cleaved by the background mixture;   contacting the enriched plurality of cells with the target protease;   isolating the cells from the enriched plurality of cells that are cleaved by the target protease; and   amplifying the isolated cells,   wherein the peptide display scaffold comprises a fusion protein having the structure [D 1 -C 1 ] TM-[D 2 ],   wherein TM is a circularly permuted transmembrane protein, wherein C 1  comprises a candidate substrate for the target protease, wherein D 1  is a first detectable moiety and is a heterologous peptide or polypeptide, wherein D 2  is a second detectable moiety and is a heterologous peptide or polypeptide, wherein D 1  and D 2  are not the same; and wherein D 1 , D 2 , and C 1  are exposed at an extracellular surface of the cell outer membrane.   
     
     
         64 . The method of  claim 63 , wherein the step of enriching the plurality of cells that are not cleaved by the target protease comprises:
 depleting the plurality of cells of cells that are cleaved by the background mixture.   
     
     
         65 . The method of  claim 63  comprising;
 detecting the presence or absence of a D 1  signal and a D 2  signal for at least one cell, wherein said detecting indicates whether C 1  is cleaved by the background mixture. 
 
     
     
         66 . The method of  claim 63  comprising;
 detecting the presence or absence of a D 1  signal and a D 2  signal for at least one cell, wherein said detecting indicates whether C 1  is cleaved by the target protease 
 
     
     
         67 . The method of  claim 63 , wherein the background mixture comprises a cellular lysate or a tissue extract. 
     
     
         68 . The method of  claim 63 , wherein the circularly permuted transmembrane protein is a circularly permuted bacterial outer membrane selected from the group consisting of: a circularly permuted OmpX, a circularly permuted OmpA, and a circularly permuted OmpT.

Join the waitlist — get patent alerts

Track US2022064629A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.